HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease.
about
Urinary metabolic profiling of rat models revealed protective function of scoparone against alcohol induced hepatotoxicityMagnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapyDiscrimination of Basal Cell Carcinoma from Normal Skin Tissue Using High-Resolution Magic Angle Spinning 1H NMR SpectroscopyMetabolomics in bladder cancer: a systematic review.Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy ControlsBiomarkers in bladder cancer: A metabolomic approach using in vitro and ex vivo model systems.Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer.Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences.Bladder cancer recurrence surveillance by urine metabolomics analysis.SPARC Inhibits Metabolic Plasticity in Ovarian Cancer
P2860
Q34397065-564A7F41-36D3-47F9-A222-E85ECDC49877Q35075617-7C3B436D-109F-4F02-9963-13E42247D960Q35943239-C59D82D7-B328-4D7B-A6E9-BB26126A424EQ36046441-AA4C2302-D891-4BB7-8863-9869BCC83947Q37110158-54A53C19-2AB1-4938-AC70-99CD9C9C3A26Q38709622-F27318C2-42A7-46A0-AF1B-A899079FD3BBQ41712406-5BA32586-0A8B-4BAB-90E2-5DF19A07BF26Q52353599-BBD4ADB4-73E7-41BC-9D1D-70DA9BAFB305Q55398059-25926D46-A502-4031-A216-F1D18D7215A5Q58551785-4C30623A-153C-493D-8E4A-25652F158A83
P2860
HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HR-MAS NMR tissue metabolomic ...... er cancer from benign disease.
@en
HR-MAS NMR tissue metabolomic ...... er cancer from benign disease.
@nl
type
label
HR-MAS NMR tissue metabolomic ...... er cancer from benign disease.
@en
HR-MAS NMR tissue metabolomic ...... er cancer from benign disease.
@nl
prefLabel
HR-MAS NMR tissue metabolomic ...... er cancer from benign disease.
@en
HR-MAS NMR tissue metabolomic ...... er cancer from benign disease.
@nl
P2093
P2860
P356
P1476
HR-MAS NMR tissue metabolomic ...... der cancer from benign disease
@en
P2093
Amy Gursky
Arul M Chinnaiyan
Bagganahalli S Somashekar
Cheryl T Lee
M Ponnusamy
Pratima Tripathi
Priya Kunju
Stephen Dailey
Thekkelnaycke M Rajendiran
P2860
P304
P356
10.1021/PR4004135
P577
2013-06-18T00:00:00Z